Rapid communicationICI 174864: A highly selective antagonist for the opioid Δ-receptor
References (5)
- et al.
Selective antagonists at the opiate delta-receptor
Life Sci.
(1982) - et al.
Differences in the inhibitory effects of normorphine and opioid peptides on the responses of the vasa deferentia of two strains of mice
European J. Pharmacol.
(1978)
Cited by (342)
Peripheral analgesia: Hitting pain where it hurts
2011, Biochimica et Biophysica Acta - Molecular Basis of DiseaseCitation Excerpt :The selective KOR agonist U50488 reduced nociceptor spontaneous activity in acutely inflamed cat knee joints [108] as well as reducing pain behaviour in Freund's complete adjuvant inflamed paws [109]. Confirmation that U50488 was producing antihyperalgesia via KORs was indicated by the blocking effects of the KOR antagonist nor-BNI [110] but not the MOR antagonist CTAP [111] nor the DOR antagonist ICI174864 [112]. The synthetic DOR agonist DPDPE has been found to be antihyperalgesic when injected locally into the inflamed rat hindpaw [109] and when administered around the primary tumour site in an animal model of bone cancer pain [113].
Transformation of μ-opioid receptor agonists into biologically potent μ-opioid receptor antagonists
2007, Bioorganic and Medicinal ChemistryOpioid profiles of Cys <sup>2</sup>-containing enkephalin analogues
2004, European Journal of PharmacologyEndogenous opioids and feeding behavior: A 30-year historical perspective
2004, PeptidesCitation Excerpt :Whereas BFNA was characterized as a short-term kappa agonist and irreversible mu antagonist [391,475,508], the irreversible though selective antagonist, naloxonazine acted at the high-affinity mu-1 receptor that binds opiates and most enkephalins with similar high affinities [177]. The development of delta antagonists began with ICI174864 that acts as a selective, short-term delta antagonist [105], albeit degrading into a peptide with mu agonist activity [90]. DALCE was then developed as a short-acting delta-1 agonist that covalently binds with the receptor acting long-term as an antagonist [50].
Synthesis and opioid activity of N,N-Dimethyl-Dmt-Tic-NH-CH(R)-R′ analogues: Acquisition of potent δ antagonism
2003, Bioorganic and Medicinal ChemistryDesign and synthesis of peptide antagonists and inverse agonists for G protein-coupled receptors
2002, Methods in Enzymology